US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Corcept Therapeutics

71.24

-0.6100-0.85%

Post-market: 71.240.00000.00%18:03 EDT

Volume:907.29K

Turnover:65.06M

Market Cap:7.55B

PE:62.36

High:73.13

Open:72.04

Low:70.78

Close:71.85

Loading ...

Overview Company News Filings

AZN to Acquire EsoBiotec for $1B to Develop In Vivo Cell Therapies

NVO Stock Down 9% as CagriSema Misses Target in Second Obesity Study

KOD Completes Enrollment in Phase III Study for Eye Disease Candidate

Top Growth Companies With Significant Insider Ownership

Simply Wall St.

BRIEF-Corcept Therapeutics launches study on link between high cortisol and resistant hypertension

INCY Opzelura Shows Superior Efficacy in 2 Prurigo Nodularis Studies

Corcept Therapeutics Initiates Momentum Trial to Determine Prevalence of Hypercortisolism in Patients With Resistant Hypertension

THOMSON REUTERS

Corcept Therapeutics Initiates MOMENTUM Trial to Determine Prevalence of Hypercortisolism in Patients with Resistant Hypertension

Corcept Shares Rise More Than 55% in 6 Months: Here's Why

Are Options Traders Betting on a Big Move in Corcept Therapeutics (CORT) Stock?

Stock Track | Corcept Therapeutics Plummets 5.03% as Full-Year and Q4 Earnings Disappoint

Truist Financial Keeps Their Buy Rating on Corcept Therapeutics (CORT)

Corcept Therapeutics: Strong Buy Rating Driven by NDA Acceptance and Promising Trial Outcomes

Corcept Therapeutics Full Year 2024 Earnings: Misses Expectations

Simply Wall St.

Branded Pharmaceuticals Stocks Q4 In Review: Bristol-Myers Squibb (NYSE:BMY) Vs Peers

FDA files Corcept’s NDA for Relacorilant as treatment in Hypercortisolism

BRIEF-FDA Files Corcept’s New Drug Application For Relacorilant As Treatment For Patients With Hypercortisolism

FDA Files Corcept’s New Drug Application for Relacorilant as Treatment for Patients With Hypercortisolism

THOMSON REUTERS

FDA Files Corcept’s New Drug Application for Relacorilant as Treatment for Patients With Hypercortisolism

3 Reasons Why Growth Investors Shouldn't Overlook Corcept (CORT)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CORT/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CORT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CORT\",,,,,undefined,":{"symbol":"CORT","market":"US","secType":"STK","nameCN":"Corcept Therapeutics","latestPrice":71.24,"timestamp":1750276800000,"preClose":71.85,"halted":0,"volume":907285,"hourTrading":{"tag":"盘后","latestPrice":71.24,"preClose":71.24,"latestTime":"18:03 EDT","volume":9435,"amount":672144.9744,"timestamp":1750284194591},"delay":0,"floatShares":87670607,"shares":106044696,"eps":1.142423,"marketStatus":"Not Yet Opened","change":-0.61,"latestTime":"06-18 16:00:00 EDT","open":72.04,"high":73.13,"low":70.7826,"amount":65059102.846099995,"amplitude":0.032671,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.142423,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750406400000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1081915200000,"exchange":"NASDAQ","adjPreClose":71.85,"preHourTrading":{"tag":"盘前","latestPrice":72,"preClose":71.85,"latestTime":"09:29 EDT","volume":28,"amount":2021.3999680000002,"timestamp":1750253395224},"postHourTrading":{"tag":"盘后","latestPrice":71.24,"preClose":71.24,"latestTime":"18:03 EDT","volume":9435,"amount":672144.9744,"timestamp":1750284194591},"volumeRatio":0.9107568049861451,"impliedVol":0.5884,"impliedVolPercentile":0.352},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CORT\",,,,,undefined,":{"symbol":"CORT","floatShares":87670607,"roa":"9.18%","roe":"21.77%","lyrEps":1.353582,"volumeRatio":0.9107568049861451,"shares":106044696,"dividePrice":0,"high":73.13,"amplitude":0.032671,"preClose":71.85,"low":70.7826,"week52Low":28.1,"pbRate":"11.06","psRate":"11.02","week52High":117.33,"institutionHeld":0.7051,"latestPrice":71.24,"eps":1.142423,"divideRate":0,"volume":907285,"delay":0,"ttmEps":1.142423,"open":72.04,"prevYearClose":50.39,"prevWeekClose":70.06,"prevMonthClose":77.56,"prevQuarterClose":114.22,"fiveDayClose":71.24,"twentyDayClose":76.22,"sixtyDayClose":59.47},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CORT\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2520576748","title":"AZN to Acquire EsoBiotec for $1B to Develop In Vivo Cell Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2520576748","media":"Zacks","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520576748?lang=en_us&edition=fundamental","pubTime":"2025-03-17 21:38","pubTimestamp":1742218680,"startTime":"0","endTime":"0","summary":"AstraZenecaAZN announced that it has entered into a definitive agreement to acquire EsoBiotec for developing in vivo cell therapies for multiple cancer indications or immune-mediated diseases. EsoBiotec is a biotechnology company specializing in “in vivo” cell therapies with promising early clinical results.The acquisition will integrate EsoBiotec’s proprietary ENaBL platform, which empowers the immune system’s ability to target cancers, into AstraZeneca’s portfolio. This technology has the potential to expand patient access to transformative cell therapy treatments, delivering results in minutes instead of the current weeks-long process. The deal will allow EsoBiotec to leverage AZN’s vast resources and expertise in cell therapies to accelerate the development of their in vivo platform which has a novel delivery technology that is expected to have broad therapeutic applicability.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/azn-acquire-esobiotec-1b-develop-133800753.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CORT","IE0002270589.USD","AZN","BK4568","BK4578","LU0289739699.SGD","IE00B3T34201.USD","LU1066051498.USD","LU2417539215.USD","LU2468319806.SGD","LU0058720904.USD","BK4139","LU2456880835.USD","BMRN","IE00B19Z3581.USD","LU0566484027.USD","LU1585245621.USD","LU2089984988.USD","LU1559883803.SGD","LU1066053197.SGD","LU2236285917.USD","GILD","LU0320765992.SGD","BK4583","LU1571399168.USD","LU2462157665.USD","LU0109394709.USD","BK4532","BK4588","LU0889565916.HKD","BK4007","IE00BKVL7J92.USD","LU2087621335.USD","BK4566","LU1829250122.USD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","BK4585","IE00B7SZLL34.SGD","BK4550","IE00BZ1G4Q59.USD","LU0234570918.USD","LU1430594728.SGD","LU1839511570.USD"],"gpt_icon":0},{"id":"2518477984","title":"NVO Stock Down 9% as CagriSema Misses Target in Second Obesity Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2518477984","media":"Zacks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518477984?lang=en_us&edition=fundamental","pubTime":"2025-03-12 01:51","pubTimestamp":1741715460,"startTime":"0","endTime":"0","summary":"Novo Nordisk NVO has achieved the primary endpoint in the second late-stage study evaluating its next-gen subcutaneous obesity treatment candidate, CagriSema, in patients with obesity and type 2 diabetes  and a mean baseline body weight of 102 kg. The results showed that treatment with the candidate led to a statistically significant and superior weight loss at week 68compared with placebo.NVO’s CagriSema is a fixed-dose combination of a long-acting amylin analogue, cagrilintide 2.4 mg and Wegovy. The two molecules promote weight loss by suppressing hunger, enhancing feelings of fullness and helping individuals consume fewer calories.The phase III REDEFINE 2 study followed a flexible protocol, enabling patients to adjust their dosing throughout the study. After 68 weeks, 61.9% of those treated with CagriSema reached the highest dose.Novo Nordisk plans to submit a regulatory application seeking the first approval for CagriSema for the obesity indication in the first quarter of 2026. Det","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nvo-stock-down-9-cagrisema-175100065.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","LU1093756168.USD","LU1430594728.SGD","IE00B19Z3581.USD","IE00BKVL7J92.USD","LU1585245621.USD","IE00BZ1G4Q59.USD","LU1093756325.SGD","BMRN","LU1559883803.SGD","LU1066053197.SGD","LU0154236417.USD","LU0566484027.USD","BK4585","LU0289739699.SGD","IE00B19Z3B42.SGD","LU2087621335.USD","BK4588","BK4578","IE00BSNM7G36.USD","LU0320765992.SGD","NVO","LU0058720904.USD","LU2468319806.SGD","LU1066051498.USD","BK4550","LU0109394709.USD","LU0234570918.USD","LU1571399168.USD","CORT","LU2089984988.USD","BK4566","BK4568","IE00B7SZLL34.SGD","BK4583","GILD","IE0002270589.USD","BK4599","BK4532","LU1839511570.USD","IE00B3T34201.USD","LU0889565916.HKD","BK4007"],"gpt_icon":1},{"id":"2518072238","title":"KOD Completes Enrollment in Phase III Study for Eye Disease Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2518072238","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518072238?lang=en_us&edition=fundamental","pubTime":"2025-03-11 22:39","pubTimestamp":1741703940,"startTime":"0","endTime":"0","summary":"Kodiak SciencesKOD announced that it has completed enrollment in a late-stage study of tarcocimab tedromer in patients with diabetic retinopathy . Per KOD, more than 250 patients have been enrolled in the phase III GLOW2 study, surpassing the initial enrollment target. With a 48-week treatment duration, all patients are expected to complete their primary endpoint visits by the end of January 2026. The top-line clinical data is anticipated to be announced in the first quarter of 2026.In late 2023, Kodiak rebooted the development program of tarcocimab following positive phase III results from the GLOW1 study, which evaluated the treatment in patients with moderately severe to severe non-proliferative diabetic retinopathy. Leveraging the GLOW1 study's success, Kodiak initiated the GLOW2 study to further investigate tarcocimab for DR and began dosing patients in May 2024. Enrolled DR patients will receive tarcocimab on extended dosing intervals, including six-month dosing for all patients.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kod-completes-enrollment-phase-iii-143900570.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0889565833.HKD","LU2054465674.USD","IE00B19Z3B42.SGD","LU1923623000.USD","BK4583","LU1951200564.SGD","IE00BSNM7G36.USD","BK4578","BMRN","LU1880398554.USD","LU0390134368.USD","LU2458330169.SGD","LU1803068979.SGD","IE00B3T34201.USD","BK4575","BK4612","LU1316542783.SGD","LU2360106780.USD","LU0056508442.USD","LU0082616367.USD","LU2468319806.SGD","BK4585","LU2089984988.USD","III","IE0009356076.USD","BK4554","LU0109394709.USD","LU1066051498.USD","BK4141","BK4550","LU1839511570.USD","BK4573","LU2458330243.SGD","LU0889565916.HKD","LU0719512351.SGD","BK4614","LU1951198990.SGD","IE00B19Z3581.USD","LU0642271901.SGD","CORT","LU2250418816.HKD","LU0320765992.SGD","LU0823434583.USD","LU2098885051.SGD","KOD","LU0127658192.USD","LU1559883803.SGD","GILD","LU1988902786.USD"],"gpt_icon":1},{"id":"2518434747","title":"Top Growth Companies With Significant Insider Ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2518434747","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518434747?lang=en_us&edition=fundamental","pubTime":"2025-03-11 19:05","pubTimestamp":1741691129,"startTime":"0","endTime":"0","summary":"As the U.S. stock market grapples with heightened volatility due to tariff concerns and recession fears, investors are increasingly seeking stability amidst uncertainty. In such an environment, growth companies with significant insider ownership can offer a unique appeal, as high insider stakes often indicate confidence in the company's long-term potential despite broader market turbulence.Top 10 Growth Companies With High Insider Ownership In The United States. Click here to see the full list of 205 stocks from our Fast Growing US Companies With High Insider Ownership screener.Overview: Corcept Therapeutics Incorporated focuses on discovering and developing medications for severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States, with a market cap of approximately $5.95 billion.Operations: The company's revenue primarily comes from the discovery, development, and commercialization of pharmaceutical products, amounting to $675.04 million.Operations: Zs","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/top-growth-companies-significant-insider-110529723.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4196","CORT","LU2125909916.SGD","LU1923622291.USD","BK4585","LU0566484027.USD","LU0390134368.USD","KULR","BK4113","BK4097","BK4007","BK4532","ZS","TBBB","BK4588","LU2286300806.USD","BK4560","LU2125909759.SGD","LU1559883803.SGD"],"gpt_icon":1},{"id":"2518768142","title":"BRIEF-Corcept Therapeutics launches study on link between high cortisol and resistant hypertension","url":"https://stock-news.laohu8.com/highlight/detail?id=2518768142","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518768142?lang=en_us&edition=fundamental","pubTime":"2025-03-10 22:54","pubTimestamp":1741618481,"startTime":"0","endTime":"0","summary":"BRIEF-Corcept Therapeutics launches study on link between high cortisol and resistant hypertensionMarch 10  - Corcept Therapeutics Inc CORT.O:CORCEPT THERAPEUTICS INITIATES MOMENTUM TRIAL TO DETERMINE PREVALENCE OF HYPERCORTISOLISM IN PATIENTS WITH RESISTANT HYPERTENSIONSource text: nBw9cq9NLaFurther company coverage: CORT.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nFWN3PT0PJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4007","CORT","LU1559883803.SGD","LU0566484027.USD"],"gpt_icon":0},{"id":"2518565270","title":"INCY Opzelura Shows Superior Efficacy in 2 Prurigo Nodularis Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2518565270","media":"Zacks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518565270?lang=en_us&edition=fundamental","pubTime":"2025-03-10 22:52","pubTimestamp":1741618320,"startTime":"0","endTime":"0","summary":"IncyteINCY announced positive results from two late-stage studies evaluating the safety and efficacy of its twice-daily ruxolitinib cream 1.5% in adults with prurigo nodularis . The data readout from both studies was recently presented at the 2025American Academy of Dermatology Annual Meeting.PN is a chronic inflammatory skin condition causing intense itching and thickened red nodules, primarily on the arms, legs, and trunk. Affecting around 200,000 people in the United States, it is most common in individuals aged 40-69. Persistent scratching leads to nodules, significantly impacting sleep and overall quality of life.Please note that ruxolitinib cream 1.5%, a topical JAK1/2 inhibitor, is currently approved in the United States under the brand name Opzelura for treating nonsegmental vitiligo in patients aged 12 and older. It is also approved for short-term and non-continuous chronictreatment of mild to moderate atopic dermatitis in non-immunocompromised patients of the same age group w","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/incy-opzelura-shows-superior-efficacy-145200413.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GILD","LU2468319806.SGD","BK4578","LU2087621335.USD","LU1066051498.USD","LU0889565916.HKD","LU0289739699.SGD","BK4568","LU1559883803.SGD","LU0058720904.USD","PN","LU1839511570.USD","BK4532","LU0234570918.USD","IE0002270589.USD","BK4566","LU1585245621.USD","LU0320765992.SGD","LU0109394709.USD","IE00B7SZLL34.SGD","LU2089984988.USD","IE00B19Z3581.USD","BK4550","BK4585","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","IE00BZ1G4Q59.USD","BK4583","BK4007","LU1571399168.USD","IE00B3T34201.USD","LU1430594728.SGD","INCY","BK4588","IE00BKVL7J92.USD","LU0566484027.USD","BK4139","BMRN","CORT","LU1066053197.SGD"],"gpt_icon":0},{"id":"2518414228","title":"Corcept Therapeutics Initiates Momentum Trial to Determine Prevalence of Hypercortisolism in Patients With Resistant Hypertension","url":"https://stock-news.laohu8.com/highlight/detail?id=2518414228","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518414228?lang=en_us&edition=fundamental","pubTime":"2025-03-10 20:02","pubTimestamp":1741608130,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nFWN3PT0PJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0566484027.USD","LU1559883803.SGD","CORT","BK4007","BK4532"],"gpt_icon":0},{"id":"2518229575","title":"Corcept Therapeutics Initiates MOMENTUM Trial to Determine Prevalence of Hypercortisolism in Patients with Resistant Hypertension","url":"https://stock-news.laohu8.com/highlight/detail?id=2518229575","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518229575?lang=en_us&edition=fundamental","pubTime":"2025-03-10 20:00","pubTimestamp":1741608000,"startTime":"0","endTime":"0","summary":"REDWOOD CITY, Calif., March 10, 2025----Corcept Therapeutics Incorporated , a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced the initiation of MOMENTUM, a clinical trial examining the prevalence of endogenous hypercortisolism  in patients with resistant hypertension.The MOMENTUM trial, which will enroll 1,000 patients across 45 sites in the U.S., will establish the prevalence of endogenous hypercortisolism in patients with resistant hypertension. Resistant hypertension is defined by the American Heart Association as elevated blood pressure despite the use of three or more antihypertensive medications in different classes, including a diuretic. Patients with a dexamethasone suppression test  value greater than 1.8 g/dL and dexamethasone levels greater than 140 ng/dL will be identified as having hypercortisolism","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/corcept-therapeutics-initiates-momentum-trial-120000275.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","CORT","LU1559883803.SGD","DST","LU0566484027.USD","BK4532"],"gpt_icon":0},{"id":"2517681456","title":"Corcept Shares Rise More Than 55% in 6 Months: Here's Why","url":"https://stock-news.laohu8.com/highlight/detail?id=2517681456","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517681456?lang=en_us&edition=fundamental","pubTime":"2025-03-07 23:56","pubTimestamp":1741362960,"startTime":"0","endTime":"0","summary":"Shares of Corcept Therapeutics Incorporated CORT have rallied 56.4% in the past six months against the industry’s decline of 10.5%.The company’s sole-marketed drug, Korlym , which is approved for treating Cushing's syndrome or endogenous hypercortisolism, has been performing well. The drug has been witnessing strong demand in recent quarters and the trend is likely to continue in 2025.The company’s top line solely comprises product sales from Korlym. Sales of the drug increased almost 40% year over year to $675 million in 2024, owing to strong demand.Corcept is also making good progress with its promising set of pipeline candidates.The company is developing its lead pipeline candidate, relacorilant for treating patients with Cushing’s syndrome. In December 2024, CORT submitted a new drug application  for relacorilant to the FDA for the same.Some other top-ranked stocks in the drug/biotech sector are Organogenesis Holdings Inc ORGO, Jazz Pharmaceuticals plc JAZZ and ANI Pharmaceuticals,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/corcept-shares-rise-more-55-155600800.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["JAZZ","IE00BN0W2T93.GBP","BK4532","BK4007","LU1559883803.SGD","ANIP","LU0823416689.USD","LU0889565916.HKD","ORGO","IE00BN0W2W23.USD","LU0320765992.SGD","LU0109394709.USD","LU0566484027.USD","BK4533","CORT","BK4139","IE00BN0W2V16.EUR"],"gpt_icon":0},{"id":"2517736434","title":"Are Options Traders Betting on a Big Move in Corcept Therapeutics (CORT) Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2517736434","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517736434?lang=en_us&edition=fundamental","pubTime":"2025-03-07 21:40","pubTimestamp":1741354800,"startTime":"0","endTime":"0","summary":"Investors in Corcept Therapeutics Incorporated CORT need to pay close attention to the stock based on moves in the options market lately. That is because the March 21, 2025 $20 Call had some of the highest implied volatility of all equity options today.Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.Clearly, options traders are pricing in a big move for Corcept Therapeutics shares, but what is the fundamental picture for the company?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/options-traders-betting-big-move-134000583.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","LU1559883803.SGD","CORT","BK4532","LU0566484027.USD"],"gpt_icon":0},{"id":"1157114218","title":"Stock Track | Corcept Therapeutics Plummets 5.03% as Full-Year and Q4 Earnings Disappoint","url":"https://stock-news.laohu8.com/highlight/detail?id=1157114218","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157114218?lang=en_us&edition=fundamental","pubTime":"2025-03-05 04:52","pubTimestamp":1741121558,"startTime":"0","endTime":"0","summary":"Corcept Therapeutics  stock plunged 5.03% in the intraday session on Tuesday, following the company's disappointing financial results for the full year 2024 and the fourth quarter.For the full year 2024, Corcept reported revenue of $675.0 million, missing analyst estimates by 2.6%. Moreover, the company's earnings per share  of $1.35 fell short of analyst expectations by 13%, further exacerbating investor concerns.The company's fourth-quarter performance was also lackluster, with revenue and EPS","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Stock Track | Corcept Therapeutics Plummets 5.03% as Full-Year and Q4 Earnings Disappoint","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["CORT"],"gpt_icon":0},{"id":"2516675399","title":"Truist Financial Keeps Their Buy Rating on Corcept Therapeutics (CORT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2516675399","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516675399?lang=en_us&edition=fundamental","pubTime":"2025-03-04 20:38","pubTimestamp":1741091899,"startTime":"0","endTime":"0","summary":"Truist Financial analyst Joon Lee maintained a Buy rating on Corcept Therapeutics (CORT – Research Report) today. The company’s shares closed yeste...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/truist-financial-keeps-their-buy-rating-on-corcept-therapeutics-cort-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/truist-financial-keeps-their-buy-rating-on-corcept-therapeutics-cort-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CORT"],"gpt_icon":0},{"id":"2516783396","title":"Corcept Therapeutics: Strong Buy Rating Driven by NDA Acceptance and Promising Trial Outcomes","url":"https://stock-news.laohu8.com/highlight/detail?id=2516783396","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516783396?lang=en_us&edition=fundamental","pubTime":"2025-03-04 19:56","pubTimestamp":1741089379,"startTime":"0","endTime":"0","summary":"Analyst Edward Nash of Canaccord Genuity maintained a Buy rating on Corcept Therapeutics (CORT – Research Report), retaining the price target of $1...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/corcept-therapeutics-strong-buy-rating-driven-by-nda-acceptance-and-promising-trial-outcomes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/corcept-therapeutics-strong-buy-rating-driven-by-nda-acceptance-and-promising-trial-outcomes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CORT"],"gpt_icon":0},{"id":"2516488620","title":"Corcept Therapeutics Full Year 2024 Earnings: Misses Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2516488620","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516488620?lang=en_us&edition=fundamental","pubTime":"2025-03-04 19:30","pubTimestamp":1741087826,"startTime":"0","endTime":"0","summary":"Profit margin: 21% . The decrease in margin was driven by higher expenses.NasdaqCM:CORT Revenue and Expenses Breakdown March 4th 2025. All figures shown in the chart above are for the trailing 12 month  period. Revenue missed analyst estimates by 2.6%. Earnings per share  also missed analyst estimates by 13%.In the last 12 months, the only revenue segment was Discovery, Development and Commercialization of Pharmaceutical Products contributing US$675.0m. The largest operating expense was General & Administrative costs, amounting to US$280.3m . Over the last 12 months, the company's earnings were enhanced by non-operating gains of US$2.78m. Explore how CORT's revenue and expenses shape its earnings.Looking ahead, revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 8.5% growth forecast for the Pharmaceuticals industry in the US.The company's shares are down 4.4% from a week ago.Just as investors must consider earnings, it is also important to take into a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/corcept-therapeutics-full-2024-earnings-113026953.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CORT"],"gpt_icon":0},{"id":"2516624909","title":"Branded Pharmaceuticals Stocks Q4 In Review: Bristol-Myers Squibb (NYSE:BMY) Vs Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2516624909","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516624909?lang=en_us&edition=fundamental","pubTime":"2025-03-04 17:03","pubTimestamp":1741078998,"startTime":"0","endTime":"0","summary":"Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Bristol-Myers Squibb  and the best and worst performers in the branded pharmaceuticals industry.The 11 branded pharmaceuticals stocks we track reported a mixed Q4. As a group, revenues beat analysts’ consensus estimates by 1.3%.In light of this news, share prices of the companies have held steady. On average, they are relatively unchanged since the latest earnings results.Founded in 1887, Bristol-Myers Squibb  is a global biopharmaceutical company that develops medicines to treat cancer, immune disorders, and cardiovascular conditions.Bristol-Myers Squibb reported revenues of $12.34 billion, up 7.5% year on year. This print exceeded analysts’ expectations by 6.6%. Despite the top-line beat, it was still a mixed quarter for the company with an impressive beat of analysts’ EPS estimates but a significant miss of analysts’ full-year E","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/branded-pharmaceuticals-stocks-q4-review-090318015.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE0002141913.USD","LU1941712348.USD","LU2468319806.SGD","LU0345774391.USD","IE00BJJMRZ35.SGD","LU0203347892.USD","NYSE","QID","TSYW.SI","LU0006306889.USD","CORT","SUPN","MRK","NVIW.SI","PSQ","SG9999014559.SGD","CNS","LU0471298777.SGD","SQQQ",".IXIC","LU1868836591.USD","LU1023059063.AUD","LU1585245621.USD","QLD","BMY","QQQ","NQmain","LU1989771016.USD","LU1035773651.USD","LU2361044949.HKD","TQQQ","USJW.SI","LU2023250843.SGD","IE00B4R5TH58.HKD","ZTS","LU1868837300.USD","USAW.SI","LU0208291251.USD","SG9999015341.SGD","MNQmain","SGXZ57979304.SGD","LU1917777945.USD","BK4534","BK4588","LU0965509101.SGD","LU0385154629.USD","LU0225284248.USD","LU0566484027.USD","IE00B19Z9505.USD","LU0882574055.USD"],"gpt_icon":0},{"id":"2516666428","title":"FDA files Corcept’s NDA for Relacorilant as treatment in Hypercortisolism","url":"https://stock-news.laohu8.com/highlight/detail?id=2516666428","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516666428?lang=en_us&edition=fundamental","pubTime":"2025-03-04 05:21","pubTimestamp":1741036877,"startTime":"0","endTime":"0","summary":"Corcept Therapeutics (CORT) announced that the FDA filed its New Drug Application (NDA) submission for its proprietary, selective cortisol modulato...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-files-corcepts-nda-for-relacorilant-as-treatment-in-hypercortisolism?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-files-corcepts-nda-for-relacorilant-as-treatment-in-hypercortisolism?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LU1559883803.SGD","LU0566484027.USD","CORT","BK4532"],"gpt_icon":0},{"id":"2516654526","title":"BRIEF-FDA Files Corcept’s New Drug Application For Relacorilant As Treatment For Patients With Hypercortisolism","url":"https://stock-news.laohu8.com/highlight/detail?id=2516654526","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516654526?lang=en_us&edition=fundamental","pubTime":"2025-03-04 05:07","pubTimestamp":1741036072,"startTime":"0","endTime":"0","summary":"BRIEF-FDA Files Corcept’s New Drug Application For Relacorilant As Treatment For Patients With HypercortisolismMarch 3 (Reuters) - Corcept Therapeutics Inc CORT.O:FDA FILES CORCEPT’S NEW DRUG APPLICAT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nTUA5TJ95B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CORT","LU0566484027.USD","LU1559883803.SGD","BK4532","BK4007"],"gpt_icon":0},{"id":"2516197665","title":"FDA Files Corcept’s New Drug Application for Relacorilant as Treatment for Patients With Hypercortisolism","url":"https://stock-news.laohu8.com/highlight/detail?id=2516197665","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516197665?lang=en_us&edition=fundamental","pubTime":"2025-03-04 05:05","pubTimestamp":1741035902,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nTUA5TJ95B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1559883803.SGD","LU0566484027.USD","CORT","BK4532","BK4007"],"gpt_icon":0},{"id":"2516666569","title":"FDA Files Corcept’s New Drug Application for Relacorilant as Treatment for Patients With Hypercortisolism","url":"https://stock-news.laohu8.com/highlight/detail?id=2516666569","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516666569?lang=en_us&edition=fundamental","pubTime":"2025-03-04 05:05","pubTimestamp":1741035900,"startTime":"0","endTime":"0","summary":"FDA assigns a Prescription Drug User Fee Act  target action date of December 30, 2025. REDWOOD CITY, Calif., March 03, 2025----Corcept Therapeutics Incorporated , a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the U.S. Food and Drug Administration  filed its New Drug Application  submission for its proprietary, selective cortisol modulator, relacorilant, to treat patients with endogenous hypercortisolism .\"The FDA’s acceptance of our New Drug Application takes us another step closer to bringing relacorilant to patients with hypercortisolism,\" said Joseph Belanoff, M.D., Corcept’s Chief Executive Officer. \"Relacorilant’s combination of efficacy and safety gives it the potential to become the new standard of care for patients struggling with the devastating impact of this disease.\"","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fda-files-corcept-drug-application-210500555.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0566484027.USD","CORT","LU1559883803.SGD","BK4532","BK4007"],"gpt_icon":0},{"id":"2516305590","title":"3 Reasons Why Growth Investors Shouldn't Overlook Corcept (CORT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2516305590","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516305590?lang=en_us&edition=fundamental","pubTime":"2025-03-01 01:45","pubTimestamp":1740764711,"startTime":"0","endTime":"0","summary":"Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a great growth stock is not easy at all.By their very nature, these stocks carry above-average risk and volatility. Moreover, if a company's growth story is over or nearing its end, betting on it could lead to significant loss.However, the task of finding cutting-edge growth stocks is made easy with the help of the Zacks Growth Style Score , which looks beyond the traditional growth attributes to analyze a company's real growth prospects.Corcept Therapeutics  is one such stock that our proprietary system currently recommends. The company not only has a favorable Growth Score, but also carries a top Zacks Rank.Research shows that stocks carrying the best growth features consistently beat the market. And for stocks that have a combination of a Growth Score of A or B and a Zacks Rank #1  or 2 , returns are even","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-reasons-why-growth-investors-174511984.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4532","CORT","BK4007","LU0566484027.USD","LU1559883803.SGD","BK4211","ISBC"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":6,"totalSize":174,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CORT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-05","symbol":"CORT","fiscalQuarterEnding":"2025/03","expectedEps":0.17,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746417600000,"reportTimeType":"post","actualEps":0.17},{"market":"US","date":"2025-02-26","symbol":"CORT","fiscalQuarterEnding":"2024/12","expectedEps":0.37,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740546000000,"reportTimeType":"post","actualEps":0.26},{"market":"US","date":"2024-10-30","symbol":"CORT","fiscalQuarterEnding":"2024/09","expectedEps":0.27,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730260800000,"reportTimeType":"post","actualEps":0.41},{"market":"US","date":"2024-07-29","symbol":"CORT","fiscalQuarterEnding":"2024/06","expectedEps":0.23,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722225600000,"reportTimeType":"post","actualEps":0.32},{"market":"US","date":"2024-05-01","symbol":"CORT","fiscalQuarterEnding":"2024/03","expectedEps":0.21,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1714536000000,"reportTimeType":"post","actualEps":0.25}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CORT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CORT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1700107200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CORT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CORT","date":"2025-06-18","current":56.863079,"percent":0.984788,"low":12.617742,"twenty":21.219667,"median":25.136412,"eighty":31.30834,"high":85.338767,"avg":27.642291,"sd":9.36101,"marketCap":7619311407},"quantilePoints":[{"date":"2020-06-19","current":17.503007,"twenty":-29.662778,"median":10.674036,"eighty":18.080162,"marketCap":1854828643},{"date":"2020-06-26","current":18.005874,"twenty":-29.662778,"median":10.737672,"eighty":18.13832,"marketCap":1908118438},{"date":"2020-07-02","current":18.579034,"twenty":-29.662778,"median":10.816326,"eighty":18.1602,"marketCap":1968857343},{"date":"2020-07-10","current":17.838251,"twenty":-29.662778,"median":10.956625,"eighty":18.168521,"marketCap":1890355173},{"date":"2020-07-17","current":17.82203,"twenty":-29.662778,"median":11.143818,"eighty":18.168521,"marketCap":1888636147},{"date":"2020-07-24","current":17.421899,"twenty":-29.662778,"median":11.212718,"eighty":18.178004,"marketCap":1846233515},{"date":"2020-07-31","current":16.167436,"twenty":-29.662778,"median":11.288088,"eighty":18.178004,"marketCap":1713295534},{"date":"2020-08-07","current":14.116479,"twenty":-29.662778,"median":11.383285,"eighty":18.178004,"marketCap":1610873724},{"date":"2020-08-14","current":13.939263,"twenty":-29.662778,"median":11.447928,"eighty":18.178004,"marketCap":1590651134},{"date":"2020-08-21","current":13.078502,"twenty":-29.662778,"median":11.607146,"eighty":18.178004,"marketCap":1492427127},{"date":"2020-08-28","current":12.769641,"twenty":-29.662778,"median":11.77016,"eighty":18.178004,"marketCap":1457182042},{"date":"2020-09-04","current":20.232944,"twenty":-29.662778,"median":12.0681,"eighty":18.192931,"marketCap":2308841966},{"date":"2020-09-11","current":17.964586,"twenty":-29.662778,"median":12.313861,"eighty":18.22447,"marketCap":2049992817},{"date":"2020-09-18","current":18.217751,"twenty":-29.662778,"median":12.50872,"eighty":18.227697,"marketCap":2078882231},{"date":"2020-09-25","current":17.306357,"twenty":-29.662778,"median":12.690857,"eighty":18.227697,"marketCap":1974880341},{"date":"2020-10-02","current":17.134205,"twenty":-29.662778,"median":12.772759,"eighty":18.227697,"marketCap":1955235539},{"date":"2020-10-09","current":18.582309,"twenty":-29.662778,"median":12.948505,"eighty":18.242559,"marketCap":2120482987},{"date":"2020-10-16","current":18.227878,"twenty":-29.662778,"median":13.039541,"eighty":18.265281,"marketCap":2080037808},{"date":"2020-10-23","current":18.075979,"twenty":-29.662778,"median":13.12871,"eighty":18.265281,"marketCap":2062704159},{"date":"2020-10-30","current":16.992433,"twenty":-29.662778,"median":13.207771,"eighty":18.265281,"marketCap":1939057467},{"date":"2020-11-06","current":19.210299,"twenty":-29.662778,"median":13.384252,"eighty":18.317545,"marketCap":2101568249},{"date":"2020-11-13","current":19.210299,"twenty":-29.662778,"median":13.650021,"eighty":18.406303,"marketCap":2101568249},{"date":"2020-11-20","current":25.411965,"twenty":-29.662778,"median":13.746278,"eighty":18.477389,"marketCap":2780018143},{"date":"2020-11-27","current":24.413752,"twenty":-29.662778,"median":13.837384,"eighty":18.52368,"marketCap":2670815591},{"date":"2020-12-04","current":25.008432,"twenty":-29.662778,"median":13.946858,"eighty":18.566015,"marketCap":2735872430},{"date":"2020-12-11","current":26.888046,"twenty":-29.662778,"median":14.03291,"eighty":18.609219,"marketCap":2941498511},{"date":"2020-12-18","current":27.88626,"twenty":-29.662778,"median":14.128307,"eighty":18.66755,"marketCap":3050701063},{"date":"2020-12-24","current":28.873854,"twenty":-29.662778,"median":14.204207,"eighty":18.752824,"marketCap":3158741885},{"date":"2020-12-31","current":27.780067,"twenty":-29.662778,"median":14.259111,"eighty":18.823955,"marketCap":3039083770},{"date":"2021-01-08","current":28.852615,"twenty":-29.662778,"median":14.437044,"eighty":18.90799,"marketCap":3156418426},{"date":"2021-01-15","current":29.882687,"twenty":-29.662778,"median":14.544352,"eighty":19.043327,"marketCap":3269106165},{"date":"2021-01-22","current":29.797732,"twenty":-29.662778,"median":14.568513,"eighty":19.173242,"marketCap":3259812331},{"date":"2021-01-29","current":30.010118,"twenty":-29.662778,"median":14.642599,"eighty":19.220775,"marketCap":3283046917},{"date":"2021-02-05","current":31.231337,"twenty":-29.662778,"median":14.727532,"eighty":19.357645,"marketCap":3416645783},{"date":"2021-02-12","current":29.734017,"twenty":-29.662778,"median":14.762883,"eighty":19.474737,"marketCap":3252841956},{"date":"2021-02-19","current":28.608372,"twenty":-29.662778,"median":14.848087,"eighty":19.754982,"marketCap":3129698653},{"date":"2021-02-26","current":27.831125,"twenty":-29.662778,"median":14.9005,"eighty":19.989119,"marketCap":2950405376},{"date":"2021-03-05","current":27.167162,"twenty":-29.662778,"median":14.992635,"eighty":20.173345,"marketCap":2880017971},{"date":"2021-03-12","current":28.428692,"twenty":-29.662778,"median":15.028869,"eighty":20.32634,"marketCap":3013754040},{"date":"2021-03-19","current":28.351229,"twenty":-29.662778,"median":15.068378,"eighty":20.471695,"marketCap":3005542176},{"date":"2021-03-26","current":27.089699,"twenty":-29.662778,"median":15.130098,"eighty":20.550186,"marketCap":2871806107},{"date":"2021-04-01","current":27.034369,"twenty":-29.662778,"median":15.171294,"eighty":20.747868,"marketCap":2865940490},{"date":"2021-04-09","current":25.09781,"twenty":-29.662778,"median":15.211446,"eighty":20.923746,"marketCap":2660643893},{"date":"2021-04-16","current":25.191871,"twenty":-29.662778,"median":15.278755,"eighty":21.20428,"marketCap":2670615442},{"date":"2021-04-23","current":26.40353,"twenty":-29.662778,"median":15.369745,"eighty":21.53034,"marketCap":2799064608},{"date":"2021-04-30","current":25.072352,"twenty":-29.662778,"median":15.47411,"eighty":22.287951,"marketCap":2657945100},{"date":"2021-05-07","current":24.754882,"twenty":-29.662778,"median":15.518576,"eighty":24.294815,"marketCap":2460907601},{"date":"2021-05-14","current":24.9074,"twenty":-29.662778,"median":15.610839,"eighty":24.413752,"marketCap":2476069591},{"date":"2021-05-21","current":25.247633,"twenty":-29.662778,"median":15.638633,"eighty":24.698476,"marketCap":2509892491},{"date":"2021-05-28","current":25.341491,"twenty":-29.662778,"median":15.686181,"eighty":24.861995,"marketCap":2519222947},{"date":"2021-06-04","current":25.11858,"twenty":-29.564231,"median":15.705567,"eighty":24.993109,"marketCap":2497063115},{"date":"2021-06-11","current":25.259366,"twenty":-29.564231,"median":15.782208,"eighty":25.114426,"marketCap":2511058798},{"date":"2021-06-18","current":26.397386,"twenty":-29.564231,"median":15.836865,"eighty":25.18427,"marketCap":2624190570},{"date":"2021-06-25","current":26.678958,"twenty":-29.564231,"median":15.876709,"eighty":25.257019,"marketCap":2652181936},{"date":"2021-07-02","current":26.174475,"twenty":-29.564231,"median":15.929368,"eighty":25.341445,"marketCap":2602030738},{"date":"2021-07-09","current":25.857706,"twenty":-29.357281,"median":15.951149,"eighty":25.408891,"marketCap":2570540451},{"date":"2021-07-16","current":23.698987,"twenty":-28.953237,"median":15.97248,"eighty":25.421286,"marketCap":2355939978},{"date":"2021-07-23","current":23.804576,"twenty":-28.83498,"median":16.047822,"eighty":25.421286,"marketCap":2366436740},{"date":"2021-07-30","current":24.668273,"twenty":7.658953,"median":16.153301,"eighty":25.421286,"marketCap":2407796084},{"date":"2021-08-06","current":25.927222,"twenty":8.529565,"median":16.182777,"eighty":25.604292,"marketCap":2530678311},{"date":"2021-08-13","current":24.561381,"twenty":8.686335,"median":16.258487,"eighty":25.617005,"marketCap":2397362687},{"date":"2021-08-20","current":24.466366,"twenty":8.870861,"median":16.364258,"eighty":25.617005,"marketCap":2388088557},{"date":"2021-08-27","current":25.570915,"twenty":9.046769,"median":16.394537,"eighty":25.617005,"marketCap":2495900322},{"date":"2021-09-03","current":25.570915,"twenty":9.231188,"median":16.443465,"eighty":25.64695,"marketCap":2495900322},{"date":"2021-09-10","current":25.06021,"twenty":9.353202,"median":16.481052,"eighty":25.64695,"marketCap":2446051871},{"date":"2021-09-17","current":24.359474,"twenty":9.563882,"median":16.545079,"eighty":25.64695,"marketCap":2377655160},{"date":"2021-09-24","current":24.098183,"twenty":9.648271,"median":16.60001,"eighty":25.64695,"marketCap":2352151302},{"date":"2021-10-01","current":23.563723,"twenty":9.818742,"median":16.632453,"eighty":25.64695,"marketCap":2299984319},{"date":"2021-10-08","current":24.157567,"twenty":9.8781,"median":16.710363,"eighty":25.642787,"marketCap":2357947633},{"date":"2021-10-15","current":23.801261,"twenty":9.911585,"median":16.806324,"eighty":25.642787,"marketCap":2323169645},{"date":"2021-10-22","current":22.233513,"twenty":10.120373,"median":16.916725,"eighty":25.642787,"marketCap":2170146494},{"date":"2021-10-29","current":21.378378,"twenty":10.16729,"median":16.975967,"eighty":25.638625,"marketCap":2086679322},{"date":"2021-11-05","current":22.428163,"twenty":10.247766,"median":17.021769,"eighty":25.638625,"marketCap":2387545188},{"date":"2021-11-12","current":24.946122,"twenty":10.405229,"median":17.108284,"eighty":25.638625,"marketCap":2655589545},{"date":"2021-11-19","current":24.805122,"twenty":10.509751,"median":17.160274,"eighty":25.638625,"marketCap":2640579691},{"date":"2021-11-26","current":23.308355,"twenty":10.517646,"median":17.193019,"eighty":25.638625,"marketCap":2481244318},{"date":"2021-12-03","current":22.679279,"twenty":10.570633,"median":17.245845,"eighty":25.638625,"marketCap":2414277277},{"date":"2021-12-10","current":20.336513,"twenty":10.633993,"median":17.285339,"eighty":25.638625,"marketCap":2164882781},{"date":"2021-12-17","current":20.45582,"twenty":10.674216,"median":17.377243,"eighty":25.638625,"marketCap":2177583426},{"date":"2021-12-23","current":19.753147,"twenty":10.722066,"median":17.416987,"eighty":25.638625,"marketCap":2102781801},{"date":"2021-12-31","current":19.703391,"twenty":10.819468,"median":17.454342,"eighty":25.638625,"marketCap":2097485121},{"date":"2022-01-07","current":18.857539,"twenty":10.913816,"median":17.567549,"eighty":25.634462,"marketCap":2007441568},{"date":"2022-01-14","current":18.359978,"twenty":11.137655,"median":17.627876,"eighty":25.634462,"marketCap":1954474772},{"date":"2022-01-21","current":17.106126,"twenty":11.176492,"median":17.634297,"eighty":25.634462,"marketCap":1820998446},{"date":"2022-01-28","current":17.524077,"twenty":11.270479,"median":17.649,"eighty":25.634462,"marketCap":1865490555},{"date":"2022-02-04","current":19.315294,"twenty":11.365143,"median":17.759255,"eighty":25.634462,"marketCap":2056171020},{"date":"2022-02-11","current":19.892464,"twenty":11.408008,"median":17.831672,"eighty":25.634462,"marketCap":2117612504},{"date":"2022-02-18","current":21.227889,"twenty":11.568834,"median":17.864938,"eighty":25.634462,"marketCap":2388392248},{"date":"2022-02-25","current":21.331486,"twenty":11.631674,"median":17.906314,"eighty":25.634462,"marketCap":2400048110},{"date":"2022-03-04","current":22.292109,"twenty":11.795058,"median":17.930398,"eighty":25.634462,"marketCap":2508129747},{"date":"2022-03-11","current":22.904271,"twenty":12.28719,"median":17.972454,"eighty":25.634462,"marketCap":2577005300},{"date":"2022-03-18","current":23.516432,"twenty":12.475052,"median":18.005093,"eighty":25.634462,"marketCap":2645880853},{"date":"2022-03-25","current":22.574645,"twenty":12.627441,"median":18.031905,"eighty":25.634462,"marketCap":2539918464},{"date":"2022-04-01","current":22.273273,"twenty":12.74917,"median":18.063294,"eighty":25.634462,"marketCap":2506010499},{"date":"2022-04-08","current":23.412836,"twenty":12.847907,"median":18.095067,"eighty":25.634462,"marketCap":2634224990},{"date":"2022-04-14","current":23.064375,"twenty":13.008366,"median":18.12447,"eighty":25.634462,"marketCap":2595018906},{"date":"2022-04-22","current":21.020696,"twenty":13.07616,"median":18.16833,"eighty":25.634462,"marketCap":2365080522},{"date":"2022-04-29","current":20.312779,"twenty":13.138468,"median":18.203209,"eighty":25.634462,"marketCap":2285431391},{"date":"2022-05-06","current":18.239814,"twenty":13.303116,"median":18.227652,"eighty":25.634462,"marketCap":2040013747},{"date":"2022-05-13","current":17.992816,"twenty":13.407715,"median":18.227652,"eighty":25.634462,"marketCap":2012388561},{"date":"2022-05-20","current":19.398802,"twenty":13.706817,"median":18.242251,"eighty":25.634462,"marketCap":2169639620},{"date":"2022-05-27","current":19.949796,"twenty":13.79308,"median":18.271684,"eighty":25.634462,"marketCap":2231265036},{"date":"2022-06-03","current":20.291793,"twenty":13.889642,"median":18.339285,"eighty":25.634462,"marketCap":2269515293},{"date":"2022-06-10","current":20.339292,"twenty":13.973328,"median":18.40556,"eighty":25.634462,"marketCap":2274827829},{"date":"2022-06-17","current":19.664799,"twenty":14.068138,"median":18.465203,"eighty":25.634462,"marketCap":2199389821},{"date":"2022-06-24","current":22.609769,"twenty":14.163827,"median":18.496311,"eighty":25.638625,"marketCap":2528767040},{"date":"2022-07-01","current":24.167753,"twenty":14.242503,"median":18.547204,"eighty":25.638625,"marketCap":2703018215},{"date":"2022-07-08","current":26.257732,"twenty":14.375881,"median":18.575405,"eighty":25.689659,"marketCap":2936769790},{"date":"2022-07-15","current":25.877736,"twenty":14.535395,"median":18.611477,"eighty":25.706312,"marketCap":2894269503},{"date":"2022-07-22","current":25.564239,"twenty":14.560417,"median":18.668127,"eighty":25.758082,"marketCap":2859206767},{"date":"2022-07-29","current":27.226722,"twenty":14.617956,"median":18.734208,"eighty":25.807402,"marketCap":3045145520},{"date":"2022-08-05","current":27.267222,"twenty":14.673898,"median":18.765235,"eighty":25.816914,"marketCap":3073915738},{"date":"2022-08-12","current":26.9917,"twenty":14.673898,"median":18.765235,"eighty":25.816914,"marketCap":3042855265},{"date":"2022-08-19","current":26.288642,"twenty":14.673898,"median":18.765235,"eighty":25.807402,"marketCap":2963597508},{"date":"2022-08-26","current":25.386069,"twenty":14.673898,"median":18.765235,"eighty":25.764749,"marketCap":2861847684},{"date":"2022-09-02","current":24.350484,"twenty":14.673898,"median":18.765235,"eighty":25.706312,"marketCap":2745103149},{"date":"2022-09-09","current":24.692512,"twenty":14.673898,"median":18.765235,"eighty":25.655304,"marketCap":2783660977},{"date":"2022-09-16","current":24.217473,"twenty":14.673898,"median":18.765235,"eighty":25.573003,"marketCap":2730108438},{"date":"2022-09-23","current":23.827942,"twenty":14.673898,"median":18.765235,"eighty":25.52154,"marketCap":2686195356},{"date":"2022-09-30","current":24.359985,"twenty":14.673898,"median":18.765235,"eighty":25.435028,"marketCap":2746174199},{"date":"2022-10-07","current":25.15805,"twenty":14.673898,"median":18.765235,"eighty":25.385744,"marketCap":2836142465},{"date":"2022-10-14","current":25.861107,"twenty":14.673898,"median":18.765235,"eighty":25.359001,"marketCap":2915400223},{"date":"2022-10-21","current":27.191216,"twenty":14.673898,"median":18.765235,"eighty":25.359001,"marketCap":3065347332},{"date":"2022-10-28","current":27.020202,"twenty":14.673898,"median":18.765235,"eighty":25.359001,"marketCap":3046068418},{"date":"2022-11-04","current":23.534301,"twenty":14.673898,"median":18.765235,"eighty":25.345826,"marketCap":2750453769},{"date":"2022-11-11","current":24.409353,"twenty":14.673898,"median":18.765235,"eighty":25.302694,"marketCap":2852721131},{"date":"2022-11-18","current":24.418564,"twenty":14.673898,"median":18.765235,"eighty":25.25389,"marketCap":2853797629},{"date":"2022-11-25","current":24.04091,"twenty":14.673898,"median":18.765235,"eighty":25.245187,"marketCap":2809661189},{"date":"2022-12-02","current":23.00927,"twenty":14.673898,"median":18.765235,"eighty":25.190124,"marketCap":2689093352},{"date":"2022-12-09","current":19.693282,"twenty":14.673898,"median":18.765235,"eighty":25.156355,"marketCap":2301553878},{"date":"2022-12-16","current":18.505053,"twenty":14.673898,"median":18.734208,"eighty":25.11858,"marketCap":2162685566},{"date":"2022-12-23","current":19.020873,"twenty":14.673898,"median":18.727537,"eighty":25.081457,"marketCap":2222969485},{"date":"2022-12-30","current":18.707697,"twenty":14.673898,"median":18.698486,"eighty":25.045958,"marketCap":2186368534},{"date":"2023-01-06","current":19.011662,"twenty":14.673898,"median":18.678417,"eighty":24.974696,"marketCap":2221892986},{"date":"2023-01-13","current":20.669656,"twenty":14.673898,"median":18.678417,"eighty":24.915538,"marketCap":2415662723},{"date":"2023-01-20","current":22.042107,"twenty":14.673898,"median":18.678417,"eighty":24.864493,"marketCap":2576061006},{"date":"2023-01-27","current":21.424965,"twenty":14.673898,"median":18.678417,"eighty":24.824329,"marketCap":2503935604},{"date":"2023-02-03","current":22.401339,"twenty":14.673898,"median":18.678417,"eighty":24.787147,"marketCap":2618044449},{"date":"2023-02-10","current":21.185477,"twenty":14.673898,"median":18.678417,"eighty":24.732601,"marketCap":2475946642},{"date":"2023-02-17","current":20.752556,"twenty":14.673898,"median":18.678417,"eighty":24.674168,"marketCap":2425351210},{"date":"2023-02-24","current":19.628805,"twenty":14.704915,"median":18.698486,"eighty":24.658704,"marketCap":2294018388},{"date":"2023-03-03","current":20.427014,"twenty":14.743485,"median":18.748075,"eighty":24.658704,"marketCap":2071666867},{"date":"2023-03-10","current":22.022874,"twenty":14.846954,"median":18.83403,"eighty":24.658704,"marketCap":2233515841},{"date":"2023-03-17","current":21.95904,"twenty":14.846954,"median":18.881519,"eighty":24.658704,"marketCap":2227041882},{"date":"2023-03-24","current":23.161255,"twenty":14.846954,"median":18.911757,"eighty":24.658704,"marketCap":2348968109},{"date":"2023-03-31","current":23.044225,"twenty":14.880165,"median":18.956878,"eighty":24.656936,"marketCap":2337099184},{"date":"2023-04-06","current":23.269603,"twenty":14.939906,"median":19.012,"eighty":24.656936,"marketCap":2359956610},{"date":"2023-04-14","current":22.558279,"twenty":14.998571,"median":19.051009,"eighty":24.658704,"marketCap":2287815518},{"date":"2023-04-21","current":22.334547,"twenty":14.998571,"median":19.104305,"eighty":24.658704,"marketCap":2265125109},{"date":"2023-04-28","current":22.344563,"twenty":14.998571,"median":19.166026,"eighty":24.658704,"marketCap":2266140860},{"date":"2023-05-05","current":25.797561,"twenty":15.006317,"median":19.199679,"eighty":24.674168,"marketCap":2437869528},{"date":"2023-05-12","current":25.70082,"twenty":15.067256,"median":19.220918,"eighty":24.732601,"marketCap":2428727517},{"date":"2023-05-19","current":25.851306,"twenty":15.164442,"median":19.305872,"eighty":24.787147,"marketCap":2442948422},{"date":"2023-05-26","current":26.356508,"twenty":15.226034,"median":19.370302,"eighty":24.824329,"marketCap":2490690034},{"date":"2023-06-02","current":24.690416,"twenty":15.273706,"median":19.394904,"eighty":24.82815,"marketCap":2333244294},{"date":"2023-06-09","current":25.840557,"twenty":15.369745,"median":19.488201,"eighty":24.87997,"marketCap":2441932643},{"date":"2023-06-16","current":24.926893,"twenty":15.394885,"median":19.593928,"eighty":24.927234,"marketCap":2355591431},{"date":"2023-06-23","current":24.023979,"twenty":15.563594,"median":19.67904,"eighty":24.927405,"marketCap":2270265997},{"date":"2023-06-30","current":23.250052,"twenty":15.628233,"median":19.743196,"eighty":24.927575,"marketCap":2197129912},{"date":"2023-07-07","current":23.615517,"twenty":15.686181,"median":19.772513,"eighty":24.927575,"marketCap":2231666397},{"date":"2023-07-14","current":24.314201,"twenty":15.761523,"median":19.849055,"eighty":24.927746,"marketCap":2297692030},{"date":"2023-07-21","current":25.077379,"twenty":15.821796,"median":19.960736,"eighty":24.935276,"marketCap":2369812337},{"date":"2023-07-28","current":26.904706,"twenty":15.876709,"median":20.074148,"eighty":25.002136,"marketCap":2542494761},{"date":"2023-08-04","current":33.858501,"twenty":15.929368,"median":20.130809,"eighty":25.06021,"marketCap":3203555971},{"date":"2023-08-11","current":33.273239,"twenty":15.97248,"median":20.230235,"eighty":25.077379,"marketCap":3148180804},{"date":"2023-08-18","current":33.067314,"twenty":16.047822,"median":20.286868,"eighty":25.09781,"marketCap":3128696949},{"date":"2023-08-25","current":34.432925,"twenty":16.153301,"median":20.335787,"eighty":25.131471,"marketCap":3257905672},{"date":"2023-09-01","current":35.473392,"twenty":16.199879,"median":20.360084,"eighty":25.165508,"marketCap":3356350414},{"date":"2023-09-08","current":35.928595,"twenty":16.288916,"median":20.424644,"eighty":25.202732,"marketCap":3399419988},{"date":"2023-09-15","current":36.633078,"twenty":16.372908,"median":20.485854,"eighty":25.247633,"marketCap":3466075282},{"date":"2023-09-22","current":34.606336,"twenty":16.402788,"median":20.528058,"eighty":25.271098,"marketCap":3274313129},{"date":"2023-09-29","current":35.755184,"twenty":16.454668,"median":20.647713,"eighty":25.318027,"marketCap":3383012531},{"date":"2023-10-06","current":28.710362,"twenty":16.484805,"median":20.739765,"eighty":25.352329,"marketCap":2716459592},{"date":"2023-10-13","current":29.935077,"twenty":16.545079,"median":20.805107,"eighty":25.396593,"marketCap":2832337257},{"date":"2023-10-20","current":30.346928,"twenty":16.62042,"median":20.91148,"eighty":25.46924,"marketCap":2871304968},{"date":"2023-10-27","current":29.870048,"twenty":16.635578,"median":20.971474,"eighty":25.500078,"marketCap":2826184461},{"date":"2023-11-03","current":28.378566,"twenty":16.744505,"median":21.039532,"eighty":25.568245,"marketCap":2593403665},{"date":"2023-11-10","current":28.097921,"twenty":16.816673,"median":21.093333,"eighty":25.60843,"marketCap":2567756602},{"date":"2023-11-17","current":28.323516,"twenty":16.948321,"median":21.176265,"eighty":25.655139,"marketCap":2588372874},{"date":"2023-11-24","current":28.571672,"twenty":16.9786,"median":21.207187,"eighty":25.701265,"marketCap":2611050772},{"date":"2023-12-01","current":28.729588,"twenty":17.023968,"median":21.222783,"eighty":25.744003,"marketCap":2625482162},{"date":"2023-12-08","current":30.15084,"twenty":17.075645,"median":21.281808,"eighty":25.795392,"marketCap":2755364672},{"date":"2023-12-15","current":33.647571,"twenty":17.145357,"median":21.387263,"eighty":25.809981,"marketCap":3074916879},{"date":"2023-12-22","current":35.711769,"twenty":17.182275,"median":21.514351,"eighty":25.859066,"marketCap":3263555762},{"date":"2023-12-29","current":37.087902,"twenty":17.245845,"median":21.57635,"eighty":25.875763,"marketCap":3389315018},{"date":"2024-01-05","current":28.582951,"twenty":17.249581,"median":21.617351,"eighty":25.902621,"marketCap":2612081586},{"date":"2024-01-12","current":26.451074,"twenty":17.300075,"median":21.662782,"eighty":26.071548,"marketCap":2417257821},{"date":"2024-01-19","current":27.906165,"twenty":17.358343,"median":21.792961,"eighty":26.115814,"marketCap":2550232772},{"date":"2024-01-26","current":25.898365,"twenty":17.391973,"median":21.940702,"eighty":26.170789,"marketCap":2366747956},{"date":"2024-02-02","current":24.398155,"twenty":17.425443,"median":22.062266,"eighty":26.170789,"marketCap":2229649751},{"date":"2024-02-09","current":25.368215,"twenty":17.524077,"median":22.147709,"eighty":26.170789,"marketCap":2318299718},{"date":"2024-02-16","current":23.855618,"twenty":17.589266,"median":22.21893,"eighty":26.191114,"marketCap":2532035310},{"date":"2024-02-23","current":22.42194,"twenty":17.626358,"median":22.234584,"eighty":26.191114,"marketCap":2379864750},{"date":"2024-03-01","current":22.919339,"twenty":17.633519,"median":22.273273,"eighty":26.186954,"marketCap":2432658618},{"date":"2024-03-08","current":22.802304,"twenty":17.633519,"median":22.340405,"eighty":26.186954,"marketCap":2420236531},{"date":"2024-03-15","current":23.085138,"twenty":17.633519,"median":22.41652,"eighty":26.186954,"marketCap":2450256573},{"date":"2024-03-22","current":24.138453,"twenty":17.633519,"median":22.460952,"eighty":26.186954,"marketCap":2562055353},{"date":"2024-03-28","current":24.694368,"twenty":17.690591,"median":22.494795,"eighty":26.186954,"marketCap":2621060264},{"date":"2024-04-05","current":24.43104,"twenty":17.751499,"median":22.557044,"eighty":26.191114,"marketCap":2593110569},{"date":"2024-04-12","current":23.303197,"twenty":17.751499,"median":22.576228,"eighty":26.191114,"marketCap":2473401294},{"date":"2024-04-19","current":22.168364,"twenty":17.751499,"median":22.605072,"eighty":26.191114,"marketCap":2352950181},{"date":"2024-04-26","current":21.728128,"twenty":17.75667,"median":22.602899,"eighty":26.186954,"marketCap":2306223456},{"date":"2024-05-03","current":22.106275,"twenty":17.75667,"median":22.608023,"eighty":26.186954,"marketCap":2609048925},{"date":"2024-05-10","current":23.464761,"twenty":17.774039,"median":22.609769,"eighty":26.186954,"marketCap":2769381540},{"date":"2024-05-17","current":24.293967,"twenty":17.84352,"median":22.678242,"eighty":26.186954,"marketCap":2867246903},{"date":"2024-05-24","current":24.558607,"twenty":17.897853,"median":22.753585,"eighty":26.186954,"marketCap":2898480529},{"date":"2024-05-31","current":26.613979,"twenty":17.929134,"median":22.805275,"eighty":26.269851,"marketCap":3141061694},{"date":"2024-06-07","current":29.38388,"twenty":17.97088,"median":22.828928,"eighty":26.282259,"marketCap":3467973651},{"date":"2024-06-14","current":25.555419,"twenty":18.005093,"median":22.904271,"eighty":26.343546,"marketCap":3016127189},{"date":"2024-06-21","current":26.499302,"twenty":18.02797,"median":22.971311,"eighty":26.356236,"marketCap":3127527123},{"date":"2024-06-28","current":28.66053,"twenty":18.069224,"median":23.033586,"eighty":26.402438,"marketCap":3382601739},{"date":"2024-07-05","current":26.534587,"twenty":18.090563,"median":23.060128,"eighty":26.439481,"marketCap":3131691607},{"date":"2024-07-12","current":27.787218,"twenty":18.146318,"median":23.147354,"eighty":26.46554,"marketCap":3279530772},{"date":"2024-07-19","current":29.886696,"twenty":18.194043,"median":23.179693,"eighty":26.56678,"marketCap":3527317541},{"date":"2024-07-26","current":31.403966,"twenty":18.227516,"median":23.238769,"eighty":26.611129,"marketCap":3706390332},{"date":"2024-08-02","current":29.278428,"twenty":18.264768,"median":23.2944,"eighty":26.712098,"marketCap":3688584155},{"date":"2024-08-09","current":28.382657,"twenty":18.351513,"median":23.371097,"eighty":26.801002,"marketCap":3575732289},{"date":"2024-08-16","current":28.175303,"twenty":18.363202,"median":23.466207,"eighty":26.905008,"marketCap":3549609171},{"date":"2024-08-23","current":28.855425,"twenty":18.363202,"median":23.50002,"eighty":26.967466,"marketCap":3635292996},{"date":"2024-08-30","current":29.278428,"twenty":18.473074,"median":23.553278,"eighty":27.007092,"marketCap":3688584155},{"date":"2024-09-06","current":28.515364,"twenty":18.498059,"median":23.60878,"eighty":27.030996,"marketCap":3592451084},{"date":"2024-09-13","current":31.60909,"twenty":18.547906,"median":23.684801,"eighty":27.154992,"marketCap":3982207993},{"date":"2024-09-20","current":35.042877,"twenty":18.547906,"median":23.765816,"eighty":27.246636,"marketCap":4414806815},{"date":"2024-09-27","current":36.436298,"twenty":18.547906,"median":23.789715,"eighty":27.295423,"marketCap":4590354163},{"date":"2024-10-04","current":37.680424,"twenty":18.547906,"median":23.805715,"eighty":27.417391,"marketCap":4747092866},{"date":"2024-10-11","current":37.680424,"twenty":18.547906,"median":23.829842,"eighty":27.588674,"marketCap":4747092866},{"date":"2024-10-18","current":41.263506,"twenty":18.547906,"median":23.855618,"eighty":27.663625,"marketCap":5198500332},{"date":"2024-10-25","current":39.214846,"twenty":18.547906,"median":23.936609,"eighty":27.785788,"marketCap":4940403934},{"date":"2024-11-01","current":35.181656,"twenty":18.547906,"median":24.002784,"eighty":27.812744,"marketCap":4989392023},{"date":"2024-11-08","current":44.032479,"twenty":18.547906,"median":24.041493,"eighty":27.882488,"marketCap":6244598165},{"date":"2024-11-15","current":38.292003,"twenty":18.547906,"median":24.098183,"eighty":28.020087,"marketCap":5430495350},{"date":"2024-11-22","current":42.510551,"twenty":18.573597,"median":24.135934,"eighty":28.172645,"marketCap":6028761382},{"date":"2024-11-29","current":42.613983,"twenty":18.589862,"median":24.157055,"eighty":28.224549,"marketCap":6043429902},{"date":"2024-12-06","current":44.904263,"twenty":18.682431,"median":24.176967,"eighty":28.282744,"marketCap":6368232826},{"date":"2024-12-13","current":40.929519,"twenty":18.769968,"median":24.222326,"eighty":28.315491,"marketCap":5804542589},{"date":"2024-12-20","current":37.974319,"twenty":18.901371,"median":24.257083,"eighty":28.37467,"marketCap":5385442041},{"date":"2024-12-27","current":38.764835,"twenty":18.949209,"median":24.285733,"eighty":28.411864,"marketCap":5497551438},{"date":"2025-01-03","current":37.571673,"twenty":19.020873,"median":24.30557,"eighty":28.448611,"marketCap":5328339592},{"date":"2025-01-10","current":36.82918,"twenty":19.096368,"median":24.341756,"eighty":28.502179,"marketCap":5223040579},{"date":"2025-01-17","current":40.863027,"twenty":19.157202,"median":24.360431,"eighty":28.556835,"marketCap":5795112827},{"date":"2025-01-24","current":44.320611,"twenty":19.197668,"median":24.395104,"eighty":28.582951,"marketCap":6285460468},{"date":"2025-01-31","current":49.440495,"twenty":19.220918,"median":24.413752,"eighty":28.623188,"marketCap":7011552168},{"date":"2025-02-07","current":50.245787,"twenty":19.315294,"median":24.431994,"eighty":28.673189,"marketCap":7125757067},{"date":"2025-02-14","current":53.725535,"twenty":19.394904,"median":24.483495,"eighty":28.714424,"marketCap":7619247962},{"date":"2025-02-21","current":46.943351,"twenty":19.52427,"median":24.530999,"eighty":28.780777,"marketCap":6657412204},{"date":"2025-02-28","current":45.261973,"twenty":19.628805,"median":24.567581,"eighty":28.855425,"marketCap":6391397910},{"date":"2025-03-07","current":41.391768,"twenty":19.741206,"median":24.656668,"eighty":28.936103,"marketCap":5844890132},{"date":"2025-03-14","current":41.847525,"twenty":19.794618,"median":24.686713,"eighty":29.038211,"marketCap":5909247226},{"date":"2025-03-21","current":43.827457,"twenty":19.949796,"median":24.719586,"eighty":29.232666,"marketCap":6188831321},{"date":"2025-03-28","current":40.816467,"twenty":20.109803,"median":24.763768,"eighty":29.323801,"marketCap":5763652490},{"date":"2025-04-04","current":55.624858,"twenty":20.215227,"median":24.801514,"eighty":29.429093,"marketCap":7854730512},{"date":"2025-04-11","current":51.269009,"twenty":20.282282,"median":24.822672,"eighty":29.544902,"marketCap":7239645503},{"date":"2025-04-17","current":46.502231,"twenty":20.336513,"median":24.830909,"eighty":29.685799,"marketCap":6566533607},{"date":"2025-04-25","current":53.852546,"twenty":20.413645,"median":24.860876,"eighty":29.851038,"marketCap":7604464217},{"date":"2025-05-02","current":54.648582,"twenty":20.564094,"median":24.917147,"eighty":29.909066,"marketCap":7716871581},{"date":"2025-05-09","current":55.580989,"twenty":20.74744,"median":24.955658,"eighty":30.172717,"marketCap":7447519000},{"date":"2025-05-16","current":59.419345,"twenty":20.920914,"median":25.011986,"eighty":30.353681,"marketCap":7961835775},{"date":"2025-05-23","current":60.218673,"twenty":21.006273,"median":25.06021,"eighty":30.435802,"marketCap":8068940918},{"date":"2025-05-30","current":61.445365,"twenty":21.056521,"median":25.074866,"eighty":30.489463,"marketCap":8233310197},{"date":"2025-06-06","current":54.615464,"twenty":21.130006,"median":25.096825,"eighty":30.662931,"marketCap":7318144470},{"date":"2025-06-13","current":56.332832,"twenty":21.192846,"median":25.11858,"eighty":31.000192,"marketCap":7548261461},{"date":"2025-06-18","current":56.863079,"twenty":21.219667,"median":25.136412,"eighty":31.30834,"marketCap":7619311407}],"updateTime":1750369639289}}}